Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-19

Clinical Trial Update: Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle [NA]

View source ↗

Summary

This completed clinical trial compares user experiences between BD Nano PRO 32G Extra Thin Wall pen needle and Terumo Nanopass 34G pen needle in diabetes patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BD Nano™ PRO 32G Extra Thin Wall Pen Needle
  • Terumo Nanopass® 34G Pen Needle

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Diabetes | NA | Status: COMPLETED | Results posted: 2020-05-19